NSD2 is a conserved driver of metastatic prostate cancer progression
Identifying cell intrinsic mechanisms promoting metastasis are necessary to develop new cancer therapeutics. Here they do cross-species computational analysis and identify nuclear receptor binding SET domain Protein 2 (NSD2) as a driver of prostate cancer metastasis.
Guardado en:
Autores principales: | Alvaro Aytes, Arianna Giacobbe, Antonina Mitrofanova, Katia Ruggero, Joanna Cyrta, Juan Arriaga, Luis Palomero, Sonia Farran-Matas, Mark A. Rubin, Michael M. Shen, Andrea Califano, Cory Abate-Shen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/64e525ee05e54b2cbb33506e939b3948 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A computational systems approach identifies synergistic specification genes that facilitate lineage conversion to prostate tissue
por: Flaminia Talos, et al.
Publicado: (2017) -
NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis
por: Suraj Peri, et al.
Publicado: (2017) -
Network-Based Analysis to Identify Drivers of Metastatic Prostate Cancer Using GoNetic
por: Louise de Schaetzen van Brienen, et al.
Publicado: (2021) -
Computational identification of mutually exclusive transcriptional drivers dysregulating metastatic microRNAs in prostate cancer
por: Mengzhu Xue, et al.
Publicado: (2017) -
Novel Biological Functions of the NsdC Transcription Factor in Aspergillus fumigatus
por: Patrícia Alves de Castro, et al.
Publicado: (2021)